News Sentiment

PAHC sentiment intelligence

Phibro Animal Health Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 32.07 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-3.6% over one week, +1.7% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction -3.6% Price reacting lower
Trend fit Trend inactive 1.7% over four weeks
Fair value 28.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 27
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 9
TradingView 8
simplywall.st 4
Business Wire 4
The Motley Fool 3
Sahm 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 9
Capital return 3
Analyst action 2
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
TradingView Direct company coverage

Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A

This article lists various ETFs that invest in Phibro Animal Health Corporation Class A stock, primarily focusing on small-cap and healthcare-related funds. It provides detailed financial data for each ETF, including market value, weight, issuer, management style, expense ratio,

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 06:41
Source
TradingView
Sahm Direct company coverage

Is Phibro Animal Health (PAHC) Undervalued After Its Russell Index Removal?

Phibro Animal Health (PAHC) has been removed from several Russell indices, impacting potential ownership and liquidity. Despite a recent stock performance dip, the company is considered 29.6% undervalued by analysts, with a fair value target of $45.60 compared to its current $32.

Tone
Neutral 50/100
Event
Analyst action
Published
04 Jul 2026 06:11
Source
Sahm
Stock Titan Direct company coverage

Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award

Phibro Animal Health Corporation's President and CEO, Daniel M. Bendheim, has been granted 300,000 Performance Stock Units (PSUs). These PSUs represent a contingent right to receive Class A Common Stock, with vesting scheduled for June 30, 2031, subject to the achievement of spec

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to revenue forward of Phibro Animal Health Corporation Class A – MUN:PB8

This article provides financial metrics for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, offering a snapshot of the comp

Tone
Neutral 50/100
Event
Earnings
Published
30 Jun 2026 04:39
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Phibro Animal Health Corporation Class A – MUN:PB8

This article provides financial information for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades. The co

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 20:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Phibro Animal Health Corporation Class A – MUN:PB8

This article displays the "Price to sales forward" value for Phibro Animal Health Corporation Class A under its Munich Stock Exchange ticker PB8. The financial data provided is limited, indicating that no specific trades or values are currently available. It appears to be a stub

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 06:13
Source
TradingView
Stock Titan Direct company coverage

New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs

Phibro Animal Health Corporation announced the appointment of Daniel (Dani) Bendheim as CEO and President, effective July 1, 2026. His compensation package includes an $850,000 annual base salary, a target 50% annual cash bonus, annual time-vesting RSUs, and an initial grant of 3

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 19:10
Source
Stock Titan
TradingView Direct company coverage

Price to book forward of Phibro Animal Health Corporation Class A – GETTEX:PB8

The article provides a title for the "Price to book forward" metric for Phibro Animal Health Corporation Class A shares traded on GETTEX under the symbol PB8. It indicates that the market is currently closed with no trades. The content seems to be a template or header from a fina

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 07:39
Source
TradingView
TradingView Direct company coverage

Phibro Animal Health Corporation Class A Actuals & Estimates (NASDAQ:PAHC)

This article provides an overview of Phibro Animal Health Corporation (NASDAQ:PAHC) stock, detailing its current price, market capitalization, and historical performance. It also includes analyst forecasts for future prices, upcoming earnings dates, and financial data such as rev

Tone
Positive 70/100
Event
Earnings
Published
25 Jun 2026 17:11
Source
TradingView
Stock Titan Direct company coverage

PHIBRO ANIMAL HEALTH CORP SEC Filing

Phibro Animal Health Corporation filed a Form 144 notice, disclosing proposed sales of 281,600 shares of Class A Common Stock. The filing details multiple smaller transactions by BFI Co. LLC, handled by Goldman Sachs & Co. LLC, which occurred between March and May 2026. These fil

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:41
Source
Stock Titan
Bez Kabli Direct company coverage

Phibro Animal Health Up 10% After Insider Move

Phibro Animal Health Corp shares rose over 10% following a director's purchase of Class A shares on the open market after a recent decline, despite ongoing investor concerns about Brazil's regulatory environment and the company's guidance. The company announced a quarterly cash d

Tone
Positive 62/100
Event
Guidance
Published
03 Jun 2026 15:07
Source
Bez Kabli
Investing.com Direct company coverage

Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock

Phibro Animal Health Corp. director E. Thomas Corcoran purchased 10,000 shares of the company's Class A Common Stock for $317,700 on May 29, 2026, at a weighted average price of $31.77 per share. This transaction increased his direct holdings to 41,459 shares. The purchase occurr

Tone
Positive 65/100
Event
Market update
Published
03 Jun 2026 05:09
Source
Investing.com
Investing.com South Africa Direct company coverage

Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com

E. Thomas Corcoran, a director at Phibro Animal Health Corp. (NASDAQ:PAHC), recently purchased 10,000 shares of the company's Class A Common Stock for a total of $317,700. This transaction occurred on May 29, 2026, at an average price of $31.77 per share. Following this purchase,

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 02:09
Source
Investing.com South Africa
Stock Titan Direct company coverage

Phibro Animal Health (PAHC) director buys 10,000 shares in market

E. Thomas Corcoran, a director at Phibro Animal Health (PAHC), purchased 10,000 shares of Class A Common Stock in an open-market transaction. The shares were bought at a weighted average price of $31.77 per share. Following this acquisition, Corcoran directly holds 41,459 shares,

Tone
Positive 71/100
Event
Deals and strategy
Published
02 Jun 2026 23:09
Source
Stock Titan
Simply Wall Street Direct company coverage

Phibro Animal Health (NasdaqGM:PAHC) Stock Forecast & Analyst Predictions

Phibro Animal Health (PAHC) is forecast to grow earnings by 15.1% and revenue by 3% annually, with EPS expected to increase by 14.9% per annum. Recent updates detail Q3 2026 earnings beats, raised outlooks, and the launch of a new sustainable solutions platform, Verratain. Analys

Tone
Positive 61/100
Event
Earnings
Published
23 May 2026 00:09
Source
Simply Wall Street
Stock Titan Direct company coverage

Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan

BFI Co., LLC and Jack C. Bendheim, major holders in Phibro Animal Health (PAHC), have filed an amended Schedule 13D disclosing a new Rule 10b5-1 sales plan. This plan authorizes Goldman Sachs to sell up to 750,000 shares of Class A Common Stock by March 17, 2027, with the first t

Tone
Neutral 50/100
Event
Market update
Published
22 May 2026 20:42
Source
Stock Titan